362703-30-8 Usage
General Description
Methyl 4-cyanotetrahydro-2H-pyran-4-carboxylate is a chemical compound with the molecular formula C8H11NO3. It is a colorless liquid with a strong, fruity odor, and it is commonly used as an intermediate in the synthesis of pharmaceuticals and agrochemicals. Methyl 4-cyanotetrahydro-2H-pyran-4-carboxylate is a versatile building block in organic chemistry, often used in the production of various drugs and other organic compounds. It is also used in the manufacturing of perfumes, flavors, and other chemical products due to its unique properties and reactivity. methyl 4-cyanotetrahydro-2H-pyran-4-carboxylate is an important chemical in the field of organic synthesis and is widely utilized in various industries for the production of a wide range of products.
Check Digit Verification of cas no
The CAS Registry Mumber 362703-30-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,6,2,7,0 and 3 respectively; the second part has 2 digits, 3 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 362703-30:
(8*3)+(7*6)+(6*2)+(5*7)+(4*0)+(3*3)+(2*3)+(1*0)=128
128 % 10 = 8
So 362703-30-8 is a valid CAS Registry Number.
362703-30-8Relevant articles and documents
NOVEL INHIBITOR OF CYCLIN-DEPENDENT KINASE CDK9
-
Paragraph 0061, (2020/03/13)
The present invention relates to an inhibitor of cyclin-dependent kinase CDK9, having a structure of formula (I). The present invention also provides a method of treating a cancer of a precancerous condition related to CDK9 activity with the inhibitor and a use of the same.
PROCESS FOR THE PREPARATION OF VENETOCLAX
-
Page/Page column 29; 30, (2018/03/06)
The present disclosure provides novel synthetic process for the preparation of venetoclax. The disclosed processes involve the use of novel intermediates. Processes for the preparation of these intermediates are also disclosed as well as methods for the preparation of particularly useful salts thereof.
3-(AMINOARYL)-PYRIDINE COMPOUNDS
-
Page/Page column 89, (2012/06/01)
The present invention provides a compound of formula (I): and pharmaceutically acceptable salts, enantiomers, stereoisomers, rotamers, tautomers, diastereomers, or racemates thereof. Also provided are pharmaceutical compositions containing these compounds and methods of treating a disease or condition mediated by CDK9 using these compounds and compositions.